| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9268246 | Journal of Clinical Virology | 2005 | 11 Pages |
Abstract
In the evolution of HAART-resistance, different patterns were observed in responders and non-responders during but not before TI. Absence of PI-resistance associated mutations during and after TI and administration of a predicted fully active PI for the new therapy correlated with success. Newly detected mutations during TI may indicate reversibility of previously described mutational pathways.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Melanie Balduin, Saleta Sierra, Martin P Däumer, Jürgen K Rockstroh, Mark Oette, Gerd Fätkenheuer, Bernd Kupfer, Niko Beerenwinkel, Daniel Hoffmann, Joachim Selbig, Herbert J Pfister, Rolf Kaiser,